Company intelligence / Profile preview
Shanghai Minwei Biotechnology Co., Ltd.
Shanghai, Shanghai, Chinaminweibiotech.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Minwei Biotechnology is a biopharmaceutical company focused on developing innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. Their pipeline includes multi-target fusion proteins and oral peptides designed to modulate key metabolic pathways.
- Therapeutic areas
- GastroenterologyEndocrinologyCardiovascularNeurology
- Modalities
- Fusion proteinSynthetic peptideMonoclonal antibodyAntibody oligonucleotide conjugates
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
03
Partnerships
Lepu Medical Technology (Beijing) Co., Ltd.
Beyond the preview
Go deeper on Shanghai Minwei Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Minwei Biotechnology Co., Ltd..